The introduction of nicotinamide for a nicotine substitute in e-cigarette and smokeless goods represents a substantial regulatory obstacle for that FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to act as a sedative at large dosages6. The promises created by Nicotin